Prognostic and predictive value of estrogen receptor 1 expression in completely resected non-small cell lung cancer.

Wolfgang Michael Brueckl* (First author), Salah-Eddin Al-Batran, Joachim H. Ficker (Co-author), Silke Claas, Akin Atmaca, Arndt Hartmann, Ralf Joachim Rieker, Ralph Markus Wirtz

*Corresponding author for this work

Research output: Contribution to journalOriginal Article (Journal)peer-review

21 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1825-1831
JournalINTERNATIONAL JOURNAL OF CANCER
Volume133
Issue number8
DOIs
Publication statusPublished - 2013

Keywords

  • CISPLATIN COMBINATION CHEMOTHERAPY
  • RANDOMIZED CONTROLLED-TRIAL
  • VINORELBINE PLUS CISPLATIN
  • IMMUNOHISTOCHEMICAL EXPRESSION
  • ADJUVANT CHEMOTHERAPY
  • MESSENGER-RNA
  • PULMONARY ADENOCARCINOMA
  • PROGESTERONE-RECEPTORS
  • POSTMENOPAUSAL WOMEN
  • ENDOCRINE THERAPY

Cite this